How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Range anxiety has haunted EV buyers since Tesla’s first Roadster, turning every road trip into a charging station treasure hunt. Factorial Energy and Karma Automotive just announced the cure: ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Neuro-linguistic programming (NLP) is a set of principles and techniques aimed at enhancing self-awareness, increasing confidence, building communication skills, and motivating positive social actions ...

Every year, millions of adults in the United States try to lose weight. Along with exercise, dieting is one of the most common methods used to promote weight loss. However, not all diets are created ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...